GLCE

glucuronic acid epimerase

Basic information

Region (hg38): 15:69160584-69272217

Links

ENSG00000138604NCBI:26035OMIM:612134HGNC:17855Uniprot:O94923AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

No genCC data.

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the GLCE gene.

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the GLCE gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
1
clinvar
1
missense
17
clinvar
1
clinvar
1
clinvar
19
nonsense
0
start loss
0
frameshift
0
inframe indel
0
splice donor/acceptor (+/-2bp)
0
splice region
0
non coding
1
clinvar
1
Total 0 0 18 1 2

Variants in GLCE

This is a list of pathogenic ClinVar variants found in the GLCE region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
15-69255858-G-A not specified Uncertain significance (Sep 14, 2022)2387343
15-69255910-A-G not specified Uncertain significance (Jun 05, 2023)2556536
15-69255920-G-T not specified Uncertain significance (Feb 17, 2022)2277451
15-69255927-C-T not specified Uncertain significance (Apr 18, 2023)2525866
15-69255964-A-C not specified Uncertain significance (Jan 18, 2022)2390691
15-69256008-G-A not specified Likely benign (Mar 27, 2023)2518073
15-69256011-G-A not specified Uncertain significance (Apr 08, 2024)3281531
15-69256054-A-G Benign (Jul 16, 2018)787120
15-69256245-G-A not specified Uncertain significance (Jan 04, 2024)3100115
15-69256323-G-T not specified Uncertain significance (Mar 25, 2024)3281529
15-69256345-A-G not specified Uncertain significance (Mar 28, 2024)3281530
15-69261171-A-G not specified Uncertain significance (Dec 02, 2021)2263132
15-69261260-A-C not specified Uncertain significance (Dec 12, 2023)3100116
15-69268261-G-T not specified Uncertain significance (Jun 19, 2024)3281533
15-69268421-G-T not specified Uncertain significance (Sep 22, 2023)3100111
15-69268493-A-T not specified Uncertain significance (Jun 10, 2024)2374270
15-69268521-C-G Benign (Jul 16, 2018)784325
15-69268580-C-G not specified Uncertain significance (Mar 17, 2023)2523388
15-69268738-G-A not specified Uncertain significance (Jan 18, 2022)2390690
15-69268747-A-G not specified Uncertain significance (Jan 10, 2023)2462918
15-69268748-C-T not specified Uncertain significance (Aug 04, 2023)2600235
15-69268753-G-A not specified Uncertain significance (Mar 31, 2024)3281528
15-69268841-A-G not specified Uncertain significance (Feb 28, 2023)3100112
15-69268939-A-C not specified Uncertain significance (Apr 11, 2023)2536058
15-69269009-G-A not specified Uncertain significance (Apr 26, 2024)3281532

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
GLCEprotein_codingprotein_codingENST00000261858 3111634
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.6540.3461257220251257470.0000994
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense1.712423290.7350.00001684076
Missense in Polyphen55120.240.457441415
Synonymous0.7081101200.9180.000005941182
Loss of Function3.43420.90.1910.00000107279

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.00006150.0000615
Ashkenazi Jewish0.00009920.0000992
East Asian0.000.00
Finnish0.0004160.000416
European (Non-Finnish)0.0001150.000114
Middle Eastern0.000.00
South Asian0.00003270.0000327
Other0.000.00

dbNSFP

Source: dbNSFP

Function
FUNCTION: Converts D-glucuronic acid residues adjacent to N- sulfate sugar residues to L-iduronic acid residues, both in maturing heparan sulfate (HS) and heparin chains. This is important for further modifications that determine the specificity of interactions between these glycosaminoglycans and proteins. {ECO:0000269|PubMed:20118238}.;
Pathway
Glycosaminoglycan biosynthesis - heparan sulfate / heparin - Homo sapiens (human);Metabolism of carbohydrates;HS-GAG biosynthesis;Heparan sulfate/heparin (HS-GAG) metabolism;Glycosaminoglycan metabolism;heparan sulfate biosynthesis (late stages);heparan sulfate biosynthesis;Metabolism (Consensus)

Recessive Scores

pRec
0.234

Intolerance Scores

loftool
0.547
rvis_EVS
0.09
rvis_percentile_EVS
60.47

Haploinsufficiency Scores

pHI
0.327
hipred
Y
hipred_score
0.626
ghis
0.548

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
S
essential_gene_gene_trap
gene_indispensability_pred
N
gene_indispensability_score
0.111

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Glce
Phenotype
respiratory system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); limbs/digits/tail phenotype; digestive/alimentary phenotype; vision/eye phenotype; skeleton phenotype; renal/urinary system phenotype; growth/size/body region phenotype; craniofacial phenotype;

Gene ontology

Biological process
heparan sulfate proteoglycan biosynthetic process;heparin biosynthetic process
Cellular component
Golgi membrane;Golgi apparatus;integral component of membrane
Molecular function
racemase and epimerase activity, acting on carbohydrates and derivatives;heparosan-N-sulfate-glucuronate 5-epimerase activity